- Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
- Hereditary Deficits in Auditory Processing Leading to Language Impairment
- The Listening Project at Reiss-Davis/Vista Del Mar Child and Family Services
- The Listening Project at the ADD Centre and Biofeedback Institute of Toronto
- The Listening Project: Tuning Into Change
- Using Nicotine to Reverse Age-related Auditory Processing Deficits
Clinical Trials
- A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP
- A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)
- A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia
- A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia
- A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
- ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia
- Autoimmune Cytopenias : Midi-Pyrenees Registry
- Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.
- Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
- Data Registry of Auto Immune Hemolytic Anemia
- Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
- Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study
- Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia
- Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
- Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
- Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia
- Immunopathology of Autoimmune Hemolytic Anemia
- National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.
- One Year Hospital Data Patients With AIHA in Assiut University Hospital – Clinical Hematology Unit
- PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy
- Presence of Circulating Cluster of Differentiation 4 Positive 28 Null T Helper Lymphocytes(CD4+CD28-) in Patients With Autoimmune Hemolytic Anemia.
- Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus
- Rituximab in Auto-Immune Hemolytic Anemia
- Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA)
- Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Subjects With Warm Autoimmune Hemolytic Anemia (wAIHA)
- Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia
- Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia
- Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia
- The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
- The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia
- The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic Anemia Before and After Tratment
- To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).
- Treatment of Autoimmune Thrombocytopenia (AITP)
- A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule
- A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis
- A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)
- A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.
- Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
- Autoimmune Hepatitis Cohort in China
- Autoimmune Hepatitis in Pediatric Patients
- Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis
- Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis
- Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis
- De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation
- Discrimination of DILI and AIH by Artificial Intelligence
- Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)
- Effect of RO7049665 on the Time to Relapse Following Steroid Tapering in Participants With Autoimmune Hepatitis (AIH)
- LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
- Liver Test Study of Using JKB-122 in AIH Patients
- Mindfulness – Based Stress Reduction and the Relationship on Inflammation in Autoimmune Hepatitis
- Mycophenolate vs Azathioprin in Autoimmune Hepatitis
- Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial
- Quantitative Magnetic Resonance Imaging to Aid Clinical Decision Making in Autoimmune Hepatitis.
- sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS
- Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy
- The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis
- Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis
- Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease
- Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV)
- Benign Paroxysmal Positional Vertigo (BPPV) in Older Patients
- Benign Paroxysmal Positional Vertigo (BPPV) Training for Sports Medicine Providers in a Pediatric Concussion Program
- Benign Paroxysmal Positional Vertigo in Older Adults
- BPPV Treatment in Biaxial Rotational Chair
- BPPV With CRP: Single Versus Multiple Cycles
- Canalith Repositioning Procedure for BPPV in Primary Care
- Comparison of Home-Based Exercise on the Posterior Canal Benign Paroxysmal Positional Vertigo Symptoms
- Cranial Osteopathic Techniques on the Symptoms of Benign Paroxysmal Positional Vertigo
- Different Treatments With the TRV Reposition Chair
- Effectiveness of Osteopathic Manipulative Treatment (OMT) and Vestibular Rehabilitation Therapy (VRT) in Individuals With Vertigo
- Effects of Physical Treatment on Postural Stability in Benign Paroxysmal Positional Vertigo (BPPV) Patients
- Efficacy of a Mechanical Chair for Treatment of Benign Paroxysmal Positional Vertigo (BPPV)
- Efficacy of Postural Restriction in Treating Benign Paroxysmal Positional Vertigo
- Efficacy of Vitamin D and Calcium Supplementation on the Prevention of Recurrences in BPPV
- Epley Manoeuvre in Participants With Multiple Sclerosis Diagnosed From Benign Paroxysmal Positional Vertigo
- Evaluation of the Efficacy of Vertistop® D and Vertistop® L in the Prevention of BPPV Recurrence
- Evaluation of the Prevalence of BPPV and Longterm Effects of Its Therapy Using the Rotundum Device in Retirement Homes
- Evidence Based Best Care Practice for Benign Paroxysmal Positional Vertigo
- Habituation Exercises Versus Proprioceptive Training in Benign Paroxysmal Positional Vertigo
- Oculomotor and Vestibular Ocular Reflex Exercises in Patients With Benign Paroxysmal Positional Vertigo
- Paroxysmal Positional Vertigo & Repositioning Maneuvers
- Serum Levels of Otolin-1 and Vitamin D in Pre- and Post-treatments of BPPV
- The Epley Maneuver Versus Cawthorne-Cooksey Exercises in the Treatment of Benign Paroxysmal Positional Vertigo (BPPV)
- The Influence of Vestibular Stimulation on Cardiac Autonomic Control System in Subjects With and Without BPPV
- The Treatment of Posterior Semicircular Canal Benign Paroxysmal Positional Vertigo
- Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
- Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo
- Treatment of Geotropic Horizontal Canal Benign Paroxysmal Positional Vertigo
- Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo
- Vertistop® D and Vertistop® L in Preventing Recurrence of High-recurrence BPPV
- A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.
- A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia
- Assessment of Cognitive Function, Fatigue and Health Related Quality of Life in Children With Beta Thalassemia
- Association of Hb F Level With Clinical Severity of Beta Thalassemia
- Atrial Fibrillation in Beta-Thalassemia
- EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)
- Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia
- Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
- Genetic Variants Affecting the Clinical Severity of Beta Thalassemia
- Iron Status in BTM With Blood Transfusion
- NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major
- Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
- Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients
- Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells
- Study on the Effect of Different Risk Factors on the Growth Parameters of Thalassemic Patients in Assiut (AUCH)
- Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)
- The Prevelence of HBB c.93-21 G-A in β Thalassemia Patients
- The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals
- The Role of OCTA in Patients Affected by Beta Thalassemia
- The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study
- Thrombin Generation in Beta-thalassemia Major
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
- A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain
- A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers
- A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors
- A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
- A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
- A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
- A Pilot Study to Assess Theragnostically Planned Liver Radiation With Functional DVH Analysis to Optimize Individualized Radiation Therapy
- A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers
- A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer
- A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma
- A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
- A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
- A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
- A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
- A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
- A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- A Study of TRK-950 in Patients With Advanced Solid Tumors
- Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver
- Advanced or Metastatic Cholangiocarcinoma
- An Exploratory Clinical Study of Photodynamic Therapy Combined With Sonodynamic Therapy in Cholangiocarcinoma
- Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
- Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer
- ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
- Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle
- Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBD
- Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter
- BKM120 in Cancers With PIK3CA Activating Mutations
- BOLD-100 in Combination With FOLFOX for the Treatment of Advanced, Solid Tumours
- CH-EUS in Diagnosis of Inoperable Bile Duct Tumors
- Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT
- Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
- Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
- Clinical Effect and Safety of PDT and RFA for Unresectable EHCC
- Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
- Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
- Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).
- Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
- Combined HCC-MFCCC
- Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers
- Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures
- Comparison of Biliary Forceps Biopsy and Brush Cytology
- Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma
- Crossover Relative Bioavailability and Dose Escalation Study of TT-00420 Tablet in Patients With Advanced Solid Tumors
- Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer
- Deep Liver Phenotyping and Immunology Study
- Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
- DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture
- Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
- Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy
- Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm
- Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy
- Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy
- Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy – (FIGHT-202)
- Efficacy of Fistulotomy for Biliary Cannulation
- Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas
- Endobiliary RFA for Unresectable Malignant Biliary Strictures
- Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer
- ENHANCED RECOVERY AFTER BILIARY TRACT SURGERY
- Etomidate vs. Midazolam for Sedation During ERCP
- EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary Obstruction
- Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images
- Evaluation of Stereotactic Radiosurgery For Liver Malignancies
- Evaluation of the Patient’s Experience in Medical Studies for Cholangiocarcinoma
- First in Human Study to Evaluate AZD8205 in Patients With Advanced or Metastatic Solid Malignancies
- FLUOPANC-trial – Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1
- Fluorescence QRH-882260 Peptide Imaging in the Bile Duct
- Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer
- Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
- Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma
- GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
- High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
- HLA Typing and Tumor Neoantigen Identification for a Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
- Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
- Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care
- Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program
- In Vitro Models of Liver and Pancreatic Cancer
- Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
- Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors
- Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma
- Irreversible Electroporation of Unresectable Liver Tumors
- Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer
- Liver Cancer Registry Platform
- Liver Embolization Approaches for Tumor Management
- Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
- Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials
- Loop-tipped Guidewire in Selective Biliary Cannulation
- LYT-200 Alone and in Combination With Chemotherapy or Anti-PD-1 in Patients With Metastatic Solid Tumors
- Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
- Margin Status After Pancreaticoduodenectomy for Cancer
- Minimally Invasive Pancreatoduodenectomy for Distal Cholangiocarcinoma
- Molecular Epidemiology of Biliary Tree Cancers
- MRCP Diagnoses EHCC Better When Combined DWI
- National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
- ncRNAs in Exosomes of Cholangiocarcinoma
- Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer
- Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma
- Neoadjuvant Therapy in Biliary Adenocarcinoma
- Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
- Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
- Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
- Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
- Open-Label Study for Safety, Tolerability, PK and Anti-Tumor Activity of STP705 Administered Intratumorally in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
- Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)
- PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer
- pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
- PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.
- Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement
- Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
- Personal Resilience Empowerment Program Study
- Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer
- Phase I/II Study Evaluating Safety and Efficacy of Tivozanib (AV-951) in Cholangiocarcinoma
- Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
- Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification
- Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
- Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
- Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
- Prognostic Factors in Periampullary Tumors and Cysts
- Prospective Evaluation of Biliary Tissue Sampling With ERCP
- Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases
- Proton Therapy and Bevacizumab for Primary Liver Tumors
- PTFE Stents for Treatment of Malignant Biliary Strictures
- QoL After Liver Surgery
- Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
- Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry.
- Radiofrequency Ablation for Biliopancreatic Malignancy
- Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies
- Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
- RALOX as Second Line Treatment for Advanced Malignant Biliary System Tumor
- Recurrence After Whipple’s (RAW): Retrospective Cohort Study Investigating Patterns of Cancer Recurrence Following Pancreaticoduodenectomy for Pancreatic Head Malignancy
- Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
- S-1 in Combination With Abraxane in Treating Cholangiocarcinoma
- Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours
- Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma
- Safety and Efficiency of Photodynamic Therapy for Blie Duct Carcinoma
- Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions
- Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
- Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors
- Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma
- Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
- Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin
- Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
- Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
- Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies
- Study of Pembrolizumab and Olaparib in Bile Duct Cancer
- Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
- Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer
- Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma
- Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients
- Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients
- Target Rare Cancer Knowledge
- The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone
- the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients
- Treatment of ARB202 Advanced Gastrointestinal Cancer Patients
- Trial of IRE in Cholangiocarcinoma
- Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma
- Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures
- Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
- A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy
- A Real World Study on Clinical Efficacy of Bicarbonate Ringer’s Solution in Biliary Atresia Children
- An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
- Clinical and Basic Study for Pediatric Liver Transplantation
- Definition for Biliary Atresia Associated Cholangitis After Surgery
- Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients
- Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
- Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice
- Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai
- GCSF Adjunct Therapy for Biliary Atresia
- High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
- Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation
- Mapping Disease Pathways for Biliary Atresia
- Maternal Microchimerism in Lymph Nodes of Infants With Biliary Atresia at Time of Kasai’s Operation
- Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy
- Obeticholic Acid in Pediatric Subjects With Biliary Atresia
- Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
- Pentoxifylline Therapy in Biliary Atresia
- Peri Kasai Portoenterostomy Anchoring of the Jejunal Loop
- RCT of Steroids Following Kasai Portoenterostomy for Biliary Atresia.
- Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
- Survival With Own Liver of Conventional Versus Laparoscopic Kasai for Biliary Atresia
- Trail to Investigate the Effectiveness of CoSeal in Reducing Adhesions Following the Kasai Hepatoportoenterostomy for Biliary Atresia